News
Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-PD-1 hIgG4 Reference Antibody (Tislbio)
Anti-PD-1 hIgG4 Reference Antibody (Tislbio)
Product Info

Cat. No:GM-86861MAB

Product:Anti-PD-1 hIgG4 Reference Antibody (Tislbio)


Cat. No. & Size

GM-86861MAB-1mg / 1 mg

GM-86861MAB-5mg / 5 mg

GM-86861MAB-25mg / 25 mg

GM-86861MAB-50mg / 50 mg

GM-86861MAB-100mg / 100 mg


Description

Expression System          CHO

Aggregation                      < 5% as determined by SEC-HPLC

Purity                                > 95% as determined by SDS-PAGE

Endotoxin                        < 1 EU/mg, determined by LAL gel clotting assay

Sterility                             0.2 μm Filtered

Target                               PD-1

Clone                               Tislelizumab

Alternative Names           CD279, PD-1, PDCD1, SLEB2, hPD-1, hPD-l, hSLE1

Source/Isotype                Human IgG4(S228P,E233P/F234V,L235A/D265A),Kappa

Application                       /

Description                       The programmed cell death 1 protein (PD-1, PDCD1, CD279) is a member of the CD28 family of immunoreceptors that regulate T cell activation and immune responses. The PD-1 protein contains an extracellular Ig V domain, a transmembrane domain, and a cytoplasmic tail that includes an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM). PD-1 is activated by the cell surface ligands PD-L1 and PD-L2. Upon activation, PD-1 ITIM and ITSM phosphorylation leads to the recruitment of the protein tyrosine phosphatases SHP-1 and SHP-2, which suppress TCR signaling. In addition to activated T-cells, PD-1 is expressed in activated B-cells and monocytes, although its function in these cell types has not been fully characterized. The PD-1 pathway plays an important role in immune tolerance; however, research studies show that cancer cells often adopt this pathway to escape immune surveillance. Consequently, blockade of PD-1 and its ligands is proving to be a sound strategy for neoplastic intervention.

Formulation                      phosphate-buffered solution, pH 7.4.

Data

image.png

image.png


Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current position:Product Center > -- > Anti-PD-1 hIgG4 Reference Antibody (Tislbio)
classify
Anti-PD-1 hIgG4 Reference Antibody (Tislbio)
Product Info

Cat. No:GM-86861MAB

Product:Anti-PD-1 hIgG4 Reference Antibody (Tislbio)


Cat. No. & Size

GM-86861MAB-1mg / 1 mg

GM-86861MAB-5mg / 5 mg

GM-86861MAB-25mg / 25 mg

GM-86861MAB-50mg / 50 mg

GM-86861MAB-100mg / 100 mg


Description

Expression System          CHO

Aggregation                      < 5% as determined by SEC-HPLC

Purity                                > 95% as determined by SDS-PAGE

Endotoxin                        < 1 EU/mg, determined by LAL gel clotting assay

Sterility                             0.2 μm Filtered

Target                               PD-1

Clone                               Tislelizumab

Alternative Names           CD279, PD-1, PDCD1, SLEB2, hPD-1, hPD-l, hSLE1

Source/Isotype                Human IgG4(S228P,E233P/F234V,L235A/D265A),Kappa

Application                       /

Description                       The programmed cell death 1 protein (PD-1, PDCD1, CD279) is a member of the CD28 family of immunoreceptors that regulate T cell activation and immune responses. The PD-1 protein contains an extracellular Ig V domain, a transmembrane domain, and a cytoplasmic tail that includes an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM). PD-1 is activated by the cell surface ligands PD-L1 and PD-L2. Upon activation, PD-1 ITIM and ITSM phosphorylation leads to the recruitment of the protein tyrosine phosphatases SHP-1 and SHP-2, which suppress TCR signaling. In addition to activated T-cells, PD-1 is expressed in activated B-cells and monocytes, although its function in these cell types has not been fully characterized. The PD-1 pathway plays an important role in immune tolerance; however, research studies show that cancer cells often adopt this pathway to escape immune surveillance. Consequently, blockade of PD-1 and its ligands is proving to be a sound strategy for neoplastic intervention.

Formulation                      phosphate-buffered solution, pH 7.4.

Data

image.png

image.png


Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit